ENTRY       D09189                      Drug
NAME        Haemophilus b conjugate vaccine (tetanus toxoid conjugate);
            Haemophilus influenzae type b conjugate vaccine;
            Acthib (TN);
            Hiberix (TN)
PRODUCT     ACTHIB (Sanofi Pasteur)
            HIBERIX (GlaxoSmithKline Biologicals SA)
REMARK      Therapeutic category: 6311
            ATC code: J07AG51
            Product: D09189<JP/US>
EFFICACY    Antiviral, Active immunization
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J07 VACCINES
               J07A BACTERIAL VACCINES
                J07AG Haemophilus influenzae b vaccines
                 J07AG51 Haemophilus influenzae b, combinations with toxoids
                  D09189  Haemophilus b conjugate vaccine (tetanus toxoid conjugate) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Vaccines
               Haemophilus Influenzae Type B (Hib)
                Haemophilus influenzae Type B Vaccine, PRP-T Conjugate
                 D09189  Haemophilus b conjugate vaccine (tetanus toxoid conjugate)
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               631  Vaccines
                6311  Bacterial vaccines
                 D09189  Haemophilus b conjugate vaccine (tetanus toxoid conjugate)
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09189
DBLINKS     PubChem: 96025869
///
